Old CIC Events
26/01/2023
VAV1 mutations act as cancer drivers in T cell lymphomas
Javier Robles Valero — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca.
19/01/2023
Unexpected noncoding RNA roles in the regulation of the cancer genome
Maite Huarte — CIMA, University of Navarra
12/01/2023
A new approach to old problems: epitranscriptomics in aging and rejuvenation
Diana Guallar — Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela
15/12/2022
Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application
Dr. Jian-Hua Mao — Lawrence Berkeley National Laboratory / University of California [Berkeley, USA]
30/11/2022
Symposium on: Cancer genomics and epitranscriptomics: from the bench to the clinic
Tony Kouzarydes, Christina Curtis, Chuan He, Núria López-Bigas, Manel Esteller, Michaela Frye, Mathieu Lupien, Vessela Kristensen, Kamil R Kranc Barts, Cristian Bellodi, Donate Weghorn, Marco Gerlinger, Direna Alonso Curbelo, Óscar Rueda, Zohar Yakhini, José Seoane — https://symposiumcic2022.usal.es/
25/11/2022
Defensa de la tesis doctoral "VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies"
Elena Navarro Carrasco — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional
24/11/2022
Hyaluronic acid is a master regulator of tumor stroma
Juan Rodríguez Vita — Centro de Investigación Príncipe Felipe, Valencia [Spain]
17/11/2022
Diversity of Quaternary Structures Regulates Nuclear Receptor Activities in Health and Disease
Eva Estébanez-Perpiñá — Institute of Biomedicine of the University of Barcelona (IBUB)
11/11/2022
Defensa de tesis: Estudio del potencial terapéutico de la herramienta de edición genómica CRISPR/Cas9 en la Leucemia Mieloide Crónica
Elena Vuelta Ramos — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional
10/11/2022
Targeted protein degradation: drug discovery opportunities & resistance mechanisms
Cristina Mayor-Ruiz — Institute for Research in Biomedicine (IRB Barcelona)
27/10/2022
Targeting KRAS: Light at the End of the Tunnel
Mariano Barbacid — Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
21/10/2022
VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies
Elena Navarro Carrasco — Centro de Investigación del Cáncer- IBMCC, Salamanca